King Wealth Management Group Has $1.88 Million Stake in Cigna Group $CI

King Wealth Management Group lessened its stake in Cigna Group (NYSE:CI) by 21.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,692 shares of the health services provider’s stock after selling 1,565 shares during the period. King Wealth Management Group’s holdings in Cigna Group were worth $1,882,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CI. Flaharty Asset Management LLC bought a new stake in Cigna Group in the first quarter valued at approximately $28,000. 1248 Management LLC bought a new position in Cigna Group during the 1st quarter worth approximately $29,000. Solstein Capital LLC acquired a new position in shares of Cigna Group in the 2nd quarter worth approximately $29,000. Activest Wealth Management boosted its stake in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 72 shares during the last quarter. Finally, Chilton Capital Management LLC acquired a new stake in shares of Cigna Group during the second quarter worth $30,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on CI. Cantor Fitzgerald dropped their target price on shares of Cigna Group from $365.00 to $325.00 in a report on Friday, October 31st. Morgan Stanley reissued an “overweight” rating and issued a $355.00 price objective on shares of Cigna Group in a research note on Friday, October 31st. Leerink Partners cut their target price on Cigna Group from $300.00 to $270.00 in a research report on Friday, October 31st. Guggenheim decreased their target price on Cigna Group from $350.00 to $309.00 in a research note on Friday, October 31st. Finally, Raymond James Financial reissued a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $334.05.

Cigna Group Trading Down 0.0%

CI opened at $270.54 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The firm has a market capitalization of $72.27 billion, a PE ratio of 14.77, a P/E/G ratio of 0.88 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The company’s 50-day moving average is $290.47 and its 200 day moving average is $301.84.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. The business had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period last year, the company posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be given a dividend of $1.51 per share. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio is presently 26.64%.

Insider Transactions at Cigna Group

In related news, CEO David Cordani acquired 4,134 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.